基亞生物科技股份有限公司/Medigen Biotechnology Corp.
基亞生物科技股份有限公司/Medigen Biotechnology Corp.
  • About
    • Company Overview
    • Our Vision
    • Corporate Structure
    • Corporate Governance
      • Board of Directors
      • Remuneration Committee
      • Organization and Operation of Internal Audit
      • Corporate Governance Status
      • Corporate Regulations
      • Corporate Social Responsibility Status
    • Management
    • Careers
    • Subsidiaries
      • Medigen Vaccine Biologics Corporation
      • TBG Diagnostics Limited
      • Winston Medical & Biotech Group
  • Cell Therapy
    • MAGICELLl–NK (Natural killer cells)
    • MAGICELL®-GDT​(T cells)
    • GTP certificated cell processing facility
    • Cell Therapy Cooperation Agency
    • Cell Therapy Regulation in Taiwan
  • COVID-19
  • CLINICAL TRIALS
    • Product Pipelines
    • NK CELL (MAGICELL-NK)
    • OBP-301 (Telomelysin)​
  • NEWS
    • Material Information
      • 2025
      • 2024
      • 2023
      • 2021
    • Financial Statement
    • Shareholder Services
  • Investors
    • Financial Statements
      • Monthly Revenue Statement
      • Quarterly and Annual Report
    • Shareholder Services
      • Share Price
      • Shareholder Meeting Document
    • Contact Information
    • Stakeholders
  • Language
    • 中文 (繁)
    • English
    • 中文 (简)

Posts by MEDIGENADMIN

Home | Posts by MEDIGENADMIN

Medigen Vaccine Biologics CO.(MVC)’s vaccine plant successfully granted the building occupancy permit

0
By MEDIGENADMIN
2015-10-16
NEWS

read more

Medigen Vaccine Biologics CO. moved its headquarter to Hsinchu Biomedical Park

0
By MEDIGENADMIN
2015-10-16
NEWS

read more

Medigen Vaccine Biologics CO. attended Stock Investment Forum hosted by Sinopac Securities Investment Trust Co.

0
By MEDIGENADMIN
2015-10-16
NEWS

read more

Medigen Vaccine Biologics CO. received 14.03 million TWD funding from Ministry of Economic Affairs for H7N9 Phase I/II clinical trial

0
By MEDIGENADMIN
2015-10-16
NEWS

read more

Medigen Vaccine Biologics CO. issued 20,000,000 new shares of the common stock for seasoned equity offering

0
By MEDIGENADMIN
2015-10-16
NEWS

read more

01/27/2015 Board of Directors Decides to Early Conclude PI-88 Phase III Trial

0
By MEDIGENADMIN
2015-01-27
NEWS

read more

Winston Medical Supply Co., Ltd. obtained the PIC/S GMP certification from FDA in Dec. 2014

0
By MEDIGENADMIN
2014-12-29
NEWS

read more

Entering of Phase II Study for Enterovirus Vaccine

0
By MEDIGENADMIN
2014-11-19
NEWS

read more

Grand Opening of TBG Biotechnology Xiamen Inc. and its Factory Plant in China

0
By MEDIGENADMIN
2014-11-10
NEWS

read more

The construction of vaccine plant for Medigen Vaccinology Corp. in Hsinchu Biomedical Park is nearly completed.

0
By MEDIGENADMIN
2014-10-23
NEWS

read more
  • News
  • Financial Statement
  • Shareholder Services
  • 1
  • 2
14F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan (R.O.C)‧Copyright© 2021-2025 Medigen Biotechnology Corp. All rights reserved.